Item Type | Name |
Academic Article
|
Recognition of PSA-derived peptide antigens by T cells from prostate cancer patients without any prior stimulation.
|
Academic Article
|
Regulation of melanoma epitope-specific cytolytic T lymphocyte response by immature and activated dendritic cells, in vitro.
|
Academic Article
|
Inhibition of c-Jun N-terminal kinase rescues influenza epitope-specific human cytolytic T lymphocytes from activation-induced cell death.
|
Academic Article
|
T cells expanded in presence of IL-15 exhibit increased antioxidant capacity and innate effector molecules.
|
Academic Article
|
Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease.
|
Concept
|
Cytokines
|
Concept
|
Immunologic Factors
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
Concept
|
T-Lymphocytes, Cytotoxic
|
Concept
|
Disease Models, Animal
|
Concept
|
Interleukin-10
|
Concept
|
Necrosis
|
Concept
|
Transforming Growth Factor beta
|
Concept
|
Interferon-beta
|
Concept
|
Lung Neoplasms
|
Concept
|
RNA, Small Interfering
|
Concept
|
Antigens
|
Concept
|
Lysophospholipids
|
Concept
|
Interferon-gamma
|
Concept
|
Interleukin-2 Receptor alpha Subunit
|
Concept
|
Receptors, Antigen, T-Cell
|
Concept
|
Ultraviolet Rays
|
Concept
|
Immunity, Cellular
|
Concept
|
Mitochondria
|
Concept
|
Flow Cytometry
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
Concept
|
Prostatic Neoplasms
|
Concept
|
Periodontal Ligament
|
Concept
|
Neoplasm Metastasis
|
Concept
|
Mitogen-Activated Protein Kinases
|
Concept
|
Recurrence
|
Concept
|
Sphingolipids
|
Concept
|
Oncogenes
|
Concept
|
Metalloporphyrins
|
Concept
|
Hematologic Neoplasms
|
Concept
|
Nitric Oxide
|
Concept
|
Mice, Inbred BALB C
|
Concept
|
Fluorescent Antibody Technique
|
Concept
|
Interleukin-15
|
Concept
|
Mitochondrial Membrane Transport Proteins
|
Concept
|
Lysosomal-Associated Membrane Protein 1
|
Concept
|
Disease Progression
|
Concept
|
CD8-Positive T-Lymphocytes
|
Concept
|
Lymphocyte Count
|
Concept
|
Ceramides
|
Concept
|
Sensitivity and Specificity
|
Concept
|
Dipeptidyl Peptidase 4
|
Concept
|
Self Tolerance
|
Concept
|
Urinary Bladder Neoplasms
|
Concept
|
HSP70 Heat-Shock Proteins
|
Concept
|
Treatment Outcome
|
Concept
|
Receptors, Interferon
|
Concept
|
Dental Pulp
|
Concept
|
Receptors, Interleukin-2
|
Concept
|
Macrophages
|
Concept
|
Bone Marrow Transplantation
|
Concept
|
Membrane Potential, Mitochondrial
|
Concept
|
Protein Kinase Inhibitors
|
Concept
|
Research Design
|
Concept
|
Carcinoma, Lewis Lung
|
Concept
|
Sirolimus
|
Concept
|
Animals
|
Concept
|
Antigens, Neoplasm
|
Concept
|
Neurodegenerative Diseases
|
Concept
|
Osteogenesis
|
Concept
|
Models, Immunological
|
Concept
|
Ovarian Neoplasms
|
Concept
|
Polylysine
|
Concept
|
ADP-ribosyl Cyclase 1
|
Concept
|
Immunophenotyping
|
Concept
|
Mice, Knockout
|
Concept
|
Immunosuppressive Agents
|
Concept
|
Cohort Studies
|
Concept
|
Antibodies
|
Concept
|
Oxidative Phosphorylation
|
Concept
|
Antineoplastic Agents
|
Concept
|
Immunotherapy, Active
|
Concept
|
Leukemia
|
Concept
|
Neoplasms, Experimental
|
Concept
|
Receptors, CCR5
|
Concept
|
Hydrogen Peroxide
|
Concept
|
Antibodies, Viral
|
Concept
|
Blotting, Western
|
Concept
|
Histocompatibility Antigens Class I
|
Concept
|
Pancreatic Neoplasms
|
Concept
|
T-Lymphocytes, Regulatory
|
Concept
|
Transplantation Tolerance
|
Concept
|
Neovascularization, Pathologic
|
Concept
|
Rats, Inbred BN
|
Concept
|
L-Selectin
|
Concept
|
T-Lymphocyte Subsets
|
Concept
|
Epitopes, T-Lymphocyte
|
Concept
|
Immunoglobulins
|
Concept
|
Prostate-Specific Antigen
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
Concept
|
Mice
|
Concept
|
Immunomodulation
|
Concept
|
Oxidants
|
Concept
|
Adenocarcinoma
|
Concept
|
Microscopy, Confocal
|
Concept
|
Histone Deacetylases
|
Concept
|
Tumor Necrosis Factor-alpha
|
Concept
|
Receptors, CCR4
|
Concept
|
Chemokine CCL22
|
Concept
|
ATP Citrate (pro-S)-Lyase
|
Concept
|
Melanoma
|
Concept
|
Interleukin-12 Subunit p35
|
Concept
|
Carbon Monoxide
|
Concept
|
Mice, Inbred C57BL
|
Concept
|
CD3 Complex
|
Concept
|
Interleukin-7
|
Concept
|
Melanoma, Experimental
|
Concept
|
HLA-A2 Antigen
|
Concept
|
Isoantigens
|
Concept
|
Mice, Transgenic
|
Concept
|
T-Lymphocytes
|
Concept
|
Antigens, CD
|
Concept
|
Epitopes
|
Concept
|
Neoplasm Invasiveness
|
Concept
|
Receptor-Interacting Protein Serine-Threonine Kinases
|
Concept
|
Disease
|
Concept
|
Interleukin-2
|
Concept
|
Free Radical Scavengers
|
Concept
|
Hemangiosarcoma
|
Concept
|
Immunoglobulin G
|
Concept
|
Xenograft Model Antitumor Assays
|
Concept
|
RNA, Messenger
|
Concept
|
Multiple Myeloma
|
Concept
|
MAP Kinase Signaling System
|
Concept
|
Humans
|
Concept
|
Multiprotein Complexes
|
Concept
|
Jurkat Cells
|
Concept
|
Receptors, CXCR3
|
Concept
|
Antigen Presentation
|
Concept
|
Pilot Projects
|
Concept
|
Membrane Glycoproteins
|
Concept
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
Concept
|
Moloney murine leukemia virus
|
Concept
|
Sirtuin 1
|
Concept
|
Glucose Transporter Type 1
|
Concept
|
Lymphocytes
|
Concept
|
Receptors, Interleukin-7
|
Concept
|
Immunodominant Epitopes
|
Concept
|
Adoptive Transfer
|
Concept
|
Cross-Priming
|
Concept
|
Inflammation
|
Concept
|
Biolistics
|
Concept
|
Interleukin-17
|
Concept
|
Survival Analysis
|
Concept
|
Coculture Techniques
|
Concept
|
Green Fluorescent Proteins
|
Concept
|
Glaucoma
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
Concept
|
Osteogenesis Imperfecta
|
Concept
|
Interleukin-1beta
|
Concept
|
Lymphocyte Activation
|
Concept
|
Cyclosporine
|
Concept
|
Antioxidants
|
Concept
|
Lymphocyte Depletion
|
Concept
|
Stem Cell Factor
|
Concept
|
Carcinoma
|
Concept
|
Autoantigens
|
Concept
|
Stilbenes
|
Concept
|
Immunotherapy, Adoptive
|
Concept
|
South Carolina
|
Concept
|
Interferon-alpha
|
Concept
|
Acetylation
|
Concept
|
Th1 Cells
|
Concept
|
Receptors, Lysosphingolipid
|
Concept
|
Mice, Nude
|
Concept
|
Graft Rejection
|
Concept
|
Case-Control Studies
|
Concept
|
Poly I-C
|
Concept
|
CD4-Positive T-Lymphocytes
|
Concept
|
JNK Mitogen-Activated Protein Kinases
|
Concept
|
HLA-A Antigens
|
Concept
|
Rats
|
Concept
|
Proto-Oncogene Proteins p21(ras)
|
Concept
|
PPAR gamma
|
Concept
|
Reperfusion Injury
|
Concept
|
Biphenyl Compounds
|
Concept
|
Spleen
|
Concept
|
Apyrase
|
Concept
|
Benzamides
|
Concept
|
Interleukin-12
|
Concept
|
5'-Nucleotidase
|
Concept
|
Enzyme Inhibitors
|
Concept
|
B-Lymphocytes
|
Concept
|
Influenza A virus
|
Concept
|
Cadaver
|
Concept
|
Vaccination
|
Concept
|
Parkinson Disease
|
Concept
|
Risk Assessment
|
Concept
|
Skin Neoplasms
|
Concept
|
Superoxides
|
Concept
|
Monophenol Monooxygenase
|
Concept
|
Glutathione S-Transferase pi
|
Concept
|
Receptors, Opioid, delta
|
Concept
|
Gene Knockdown Techniques
|
Concept
|
Immunohistochemistry
|
Concept
|
Immune Tolerance
|
Concept
|
Anthracenes
|
Concept
|
Immunologic Memory
|
Academic Article
|
Reducing CD73 expression by IL1?-Programmed Th17 cells improves immunotherapeutic control of tumors.
|
Academic Article
|
Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cells.
|
Academic Article
|
Lack of p53 Augments Antitumor Functions in Cytolytic T Cells.
|
Academic Article
|
Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation.
|
Academic Article
|
Antigen Specificity Enhances Disease Control by Tregs in Vitiligo.
|
Academic Article
|
The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling.
|
Concept
|
Melanoma-Specific Antigens
|
Concept
|
gp100 Melanoma Antigen
|
Concept
|
MART-1 Antigen
|
Concept
|
Mechanistic Target of Rapamycin Complex 1
|
Concept
|
Th17 Cells
|
Concept
|
Inflammasomes
|
Concept
|
GPI-Linked Proteins
|
Concept
|
Real-Time Polymerase Chain Reaction
|
Concept
|
Inducible T-Cell Co-Stimulator Protein
|
Concept
|
Programmed Cell Death 1 Receptor
|
Concept
|
Antibodies, Monoclonal, Humanized
|
Concept
|
Mitochondrial Dynamics
|
Concept
|
Spike Glycoprotein, Coronavirus
|
Concept
|
Triple Negative Breast Neoplasms
|
Concept
|
ELAV-Like Protein 1
|
Concept
|
Bortezomib
|
Concept
|
Enhancer of Zeste Homolog 2 Protein
|